Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction.

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving ...

(NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but ...

Illumina Has Acquired GRAIL to Usher. In A New Era of Cancer Detection. Detecting Cancer Early, When it Can be Cured. Transformative. Multi-Cancer Early.

Illumina's Acquisition of GRAIL: A Comparison of the Outcomes

[1] Press Release, Illumina, Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test (Aug. 18, ...

Illumina Remains Committed to GRAIL Acquisition to Accelerate ...

“Reuniting GRAIL and Illumina will allow us to bring GRAIL's breakthrough early detection multi-cancer test to patients across the world faster and consequently ...

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate ...

Illumina will pursue its right to proceed with the transaction, the impact of which would accelerate the adoption of a breakthrough multi-cancer early ...

Illumina buys spinout Grail, betting $8B on the future of cancer ...

Illumina has agreed to acquire Grail in an $8 billion deal that could establish the sequencing giant as a leading player in the growing race to ...

Illumina to acquire GRAIL to launch new era of cancer detection

Illumina, and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, announced they have entered into a ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and ...

Illumina to Acquire Grail for $8B in Cash and Stock

Grail plans to launch a multi-cancer blood-based screening test ... cancer detection when treatment can be more effective and less costly.

Press Releases - GRAIL

Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25 GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology ...

transcript - SEC.gov

... Illumina to acquire GRAIL. (Operator Instructions). I'd now ... acquire GRAIL and to work together to launch a new era in cancer detection.

Illumina Acquires Grail - San Diego Business Journal

Illumina CEO Francis deSouza said the acquisition will launch a “new era” in early cancer detection, and Illumina's chief medical officer Dr.

Illumina/GRAIL: EC Blocks Transaction Below EU and Referring ...

[4] Illumina Press Release, Illumina to Acquire GRAIL to Launch New Era of Cancer Detection, September 21, 2020. [5] Commission Guidance on the ...

Illumina to acquire GRAIL to launch new era of cancer detection ...

Illumina (NASDAQ:ILMN) to acquire GRAIL (GRAL) for a $3.5B cash and $4.5B stock consideration of $8B and additional future payments representing a tiered...

Illumina/Grail - Federal Trade Commission

potential profits available to Illumina from GRAIL's early cancer detection business are ... large-scale efforts to launch an MCED test that will ...

Mergers: Commission prohibits acquisition of GRAIL by Illumina

The merger would have stifled innovation, and reduced choice in the emerging market for blood-based early cancer detection tests. Illumina did ...

Illumina to acquire start-up GRAIL - Launch new era of cancer ...

Launch new era of cancer detection ... Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and ...

FTC Orders Illumina to Divest Cancer Detection Test Maker GRAIL ...

Illumina can easily foreclose GRAIL's competitors by raising their costs or withholding or degrading access to supply, service, or new ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection. SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ...